ExodusPoint Capital Management, LP - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$120,000
+93.5%
14,548
+31.7%
0.00%
+100.0%
Q1 2022$62,000
+17.0%
11,044
-2.0%
0.00%0.0%
Q4 2021$53,000
-89.3%
11,264
-85.0%
0.00%
-80.0%
Q2 2021$494,000
+236.1%
75,015
+273.7%
0.01%
+150.0%
Q1 2021$147,000
-24.6%
20,072
-47.1%
0.00%
-60.0%
Q2 2020$195,00037,9240.01%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
PATHWAY CAPITAL MANAGEMENT, LP 245,606$3,671,8106.55%
AIGH Capital Management LLC 695,358$10,395,6023.42%
BARDIN HILL MANAGEMENT PARTNERS LP 638,360$9,5442.08%
Kellner Capital, LLC 100,016$1,4951.74%
NEXPOINT ASSET MANAGEMENT, L.P. 1,464,807$21,898,8651.70%
Worth Venture Partners, LLC 170,925$2,555,3291.51%
Birchview Capital, LP 100,000$1,4951.06%
BCK CAPITAL MANAGEMENT LP 68,000$1,016,6001.05%
WATER ISLAND CAPITAL LLC 698,915$10,4490.89%
EHP Funds Inc. 292,043$4,3660.82%
View complete list of AVEO PHARMACEUTICALS INC shareholders